No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * |
KEGG DRUG * |
DrugBank |
指定難病告示番号 * |
1 | AGE-RAGE signaling pathway in diabetic complications 2 genes, 2 drugs (DrugBank) and 5 diseases shown |
1件: VEGFA |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
2件: VEGFA, VEGFB |
D09574 |
Aflibercept |
2件: 90, 166 |
2 | Bladder cancer 1 gene, 2 drugs (DrugBank) and 5 diseases shown |
1件: VEGFA |
D09574 |
Aflibercept |
2件: 90, 166 |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
3 | Collecting duct acid secretion 2 genes, 1 drug (DrugBank) and 6 diseases shown |
2件: ATP4A, ATP4B |
D00355 |
Lansoprazole |
6件: 63, 71, 98, 166, 222, 299 |
4 | EGFR tyrosine kinase inhibitor resistance 1 gene, 2 drugs (DrugBank) and 5 diseases shown |
1件: VEGFA |
D09574 |
Aflibercept |
2件: 90, 166 |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
5 | Fluid shear stress and atherosclerosis 1 gene, 2 drugs (DrugBank) and 5 diseases shown |
1件: VEGFA |
D09574 |
Aflibercept |
2件: 90, 166 |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
6 | Focal adhesion 3 genes, 2 drugs (DrugBank) and 5 diseases shown |
3件: PGF, VEGFA, VEGFB |
D09574 |
Aflibercept |
2件: 90, 166 |
1件: VEGFA |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
7 | Gastric acid secretion 2 genes, 1 drug (DrugBank) and 6 diseases shown |
2件: ATP4A, ATP4B |
D00355 |
Lansoprazole |
6件: 63, 71, 98, 166, 222, 299 |
8 | HIF-1 signaling pathway 1 gene, 2 drugs (DrugBank) and 5 diseases shown |
1件: VEGFA |
D09574 |
Aflibercept |
2件: 90, 166 |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
9 | Human cytomegalovirus infection 1 gene, 2 drugs (DrugBank) and 5 diseases shown |
1件: VEGFA |
D09574 |
Aflibercept |
2件: 90, 166 |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
10 | Human papillomavirus infection 1 gene, 2 drugs (DrugBank) and 5 diseases shown |
1件: VEGFA |
D09574 |
Aflibercept |
2件: 90, 166 |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
11 | Kaposi sarcoma-associated herpesvirus infection 1 gene, 2 drugs (DrugBank) and 5 diseases shown |
1件: VEGFA |
D09574 |
Aflibercept |
2件: 90, 166 |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
12 | MAPK signaling pathway 3 genes, 2 drugs (DrugBank) and 5 diseases shown |
3件: PGF, VEGFA, VEGFB |
D09574 |
Aflibercept |
2件: 90, 166 |
1件: VEGFA |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
13 | Metabolic pathways 2 genes, 1 drug (DrugBank) and 6 diseases shown |
2件: ATP4A, ATP4B |
D00355 |
Lansoprazole |
6件: 63, 71, 98, 166, 222, 299 |
14 | MicroRNAs in cancer 1 gene, 2 drugs (DrugBank) and 5 diseases shown |
1件: VEGFA |
D09574 |
Aflibercept |
2件: 90, 166 |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
15 | Oxidative phosphorylation 2 genes, 1 drug (DrugBank) and 6 diseases shown |
2件: ATP4A, ATP4B |
D00355 |
Lansoprazole |
6件: 63, 71, 98, 166, 222, 299 |
16 | Pancreatic cancer 1 gene, 2 drugs (DrugBank) and 5 diseases shown |
1件: VEGFA |
D09574 |
Aflibercept |
2件: 90, 166 |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
17 | Pathways in cancer 3 genes, 2 drugs (DrugBank) and 5 diseases shown |
3件: PGF, VEGFA, VEGFB |
D09574 |
Aflibercept |
2件: 90, 166 |
1件: VEGFA |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
18 | PI3K-Akt signaling pathway 3 genes, 2 drugs (DrugBank) and 5 diseases shown |
3件: PGF, VEGFA, VEGFB |
D09574 |
Aflibercept |
2件: 90, 166 |
1件: VEGFA |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
19 | Proteoglycans in cancer 1 gene, 2 drugs (DrugBank) and 5 diseases shown |
1件: VEGFA |
D09574 |
Aflibercept |
2件: 90, 166 |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
20 | Rap1 signaling pathway 3 genes, 2 drugs (DrugBank) and 5 diseases shown |
3件: PGF, VEGFA, VEGFB |
D09574 |
Aflibercept |
2件: 90, 166 |
1件: VEGFA |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
21 | Ras signaling pathway 3 genes, 2 drugs (DrugBank) and 5 diseases shown |
3件: PGF, VEGFA, VEGFB |
D09574 |
Aflibercept |
2件: 90, 166 |
1件: VEGFA |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
22 | Relaxin signaling pathway 2 genes, 2 drugs (DrugBank) and 5 diseases shown |
1件: VEGFA |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
2件: VEGFA, VEGFB |
D09574 |
Aflibercept |
2件: 90, 166 |
23 | Renal cell carcinoma 1 gene, 2 drugs (DrugBank) and 5 diseases shown |
1件: VEGFA |
D09574 |
Aflibercept |
2件: 90, 166 |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
24 | Rheumatoid arthritis 1 gene, 2 drugs (DrugBank) and 5 diseases shown |
1件: VEGFA |
D09574 |
Aflibercept |
2件: 90, 166 |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |
25 | VEGF signaling pathway 1 gene, 2 drugs (DrugBank) and 5 diseases shown |
1件: VEGFA |
D09574 |
Aflibercept |
2件: 90, 166 |
D05697 |
Ranibizumab |
4件: 34, 166, 227, 301 |